Testing for attention may boost safe driver screens

Article

Results of research focusing on driver safety suggest that it may be possible to improve current techniques of screening for at-risk drivers through the addition of new tests of attentional abilities.

Results of research focusing on driver safety suggest that it may be possible to improve current techniques of screening for at-risk drivers through the addition of new tests of attentional abilities, reported Alex Bowers, PhD, MCOptom, FAAO, recently.

Dr. Bowers presented the findings from a study of drivers attending "DriveWise," a local clinical driving assessment program based at Beth Israel Deaconess Medical Center. Participants completed a screening test battery, followed by a 45-minute on-road driving test in a dual-control car with an occupational therapist and a certified driving rehabilitation specialist.

In addition to the usual DriveWise neuropsychological assessment, the screening battery included the Useful Field of View test (Posit Science Corporation, San Francisco), a well-established test of static attention, and a new test of dynamic attention requiring sustained tracking of multiple moving objects. Both tests evaluated the ability to divide attention, which may be important when driving, for example, when looking at the car ahead while being aware of a pedestrian about to step off the curb.

"Older drivers are the most rapidly growing segment of the driving population. Changes in vision, attention, and cognition that occur with aging along with other physical impairments may adversely affect driving safety," she said.

"Ideally, at-risk older drivers would be accurately identified in a short screening test, but it is not that simple because of the wide range of factors affecting safe driving," Dr. Bowers noted.

The research team, including Dr. Bowers, Todd Horowitz, PhD (Visual Attention Lab, Brigham and Women's) and Margaret O'Connor, PhD (Cognitive Neurology, Beth Israel), is currently analyzing the data to determine which test or combination of tests best predicts the road test outcome, correctly categorizing drivers as being at-risk or safe.

Dr. Bowers also mentioned that, to the best of her knowledge, this is the first study to evaluate the relationship between dynamic attention and driving performance. She said the research team now plans to study in more detail how dynamic attention is important in driving.

FYI

Alex Bowers, PhD, MCOptom, FAAOE-mail: alex.bowers@schepens.harvard.edu

Dr. Bowers did not indicate a financial interest in the subject.

Recent Videos
Cecilia Koetting, OD, FAAO, DipABO, cited data from a recent student that found that presbyopia treatment with 0.4% pilocarpine led to up to 86% of patients achieving 20/40 or better.
Kerry Giedd, OD, MS, FAAO, was 1 of 20 investigators around the country for a study evaluating the daily disposable contact lens.
According to A. Paul Chous, MA, OD, FAAO, optometrists have an important opportunity to educate patients in their chairs about diabetes.
David Geffen, OD, FAAO, gave a poster presentation titled "Revolutionizing Comfort: Unveiling the Potential of Perfluorohexyloctane Eyedrops for Contact Lens Wearers" at this year's Academy meeting.
Jessica Steen, OD, FAAO, Dipl-ABO, discussed ophthalmic considerations for patients undergoing treatment with antibody drug conjugates for gynecologic cancers at this year's conference.
A. Paul Chous, MA, OD, FAAO, details a presentation on this year's updates on diabetes given at this year's Academy meeting
Sherrol Reynolds, OD, FAAO, said that multimodel imaging has been a game changer in assessing the choroidal function and structural changes in various disease conditions.
Susan Gromacki, OD, FAAO, FSLS, provides key takeaways from this year's American Academy of Optometry symposium genetics and the cornea.
Roya Attar gives an overview of her presentation, "Decoding the Retina: The Value of Genetic Testing In Inherited Disorders," presented with Mohammad Rafieetary, OD, FAAO, FORS, ABO, ABCMO.
Ian Ben Gaddie, OD, FAAO, outlines key findings from a recent study evaluating lotilaner in patients with Demodex blepharitis and meibomian gland dysfunction.
© 2024 MJH Life Sciences

All rights reserved.